BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2780743)

  • 1. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S; Paul E; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
    Prager RL; Dunn EL; Kirsh MM; Penner JA
    Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
    Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
    von Kries R; Stannigel H; Göbel U
    Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of DIC with antithrombin III concentrates.
    Sakata Y; Yoshida N; Matsuda M; Aoki N
    Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
    Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
    Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
    Dickneite G; Pâques EP
    Thromb Haemost; 1993 Feb; 69(2):98-102. PubMed ID: 8456437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
    Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
    Emerson TE; Fournel MA; Leach WJ; Redens TB
    Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
    Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
    Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III and sepsis.
    Mammen EF
    Intensive Care Med; 1998 Jul; 24(7):649-50. PubMed ID: 9722032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.